Boston scientific corporation (BSX)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09Sep'09Jun'09Mar'09Sep'08Jun'08
Net sales

2,543

2,904

2,707

2,631

2,493

2,561

2,393

2,490

2,379

2,409

2,222

2,257

2,160

2,191

2,105

2,126

1,964

1,978

1,888

1,843

1,768

1,887

1,846

1,873

1,774

1,838

1,735

1,809

1,761

1,820

1,735

1,828

1,866

1,848

1,874

1,975

1,925

2,002

1,916

1,928

1,960

2,079

2,025

2,074

2,010

1,978

2,024

Cost of products sold

806

851

777

758

730

730

672

739

672

674

637

632

650

618

594

639

573

574

539

540

520

560

550

563

537

556

510

530

578

582

558

578

631

660

680

688

631

659

623

654

663

710

629

630

607

655

604

Gross profit

1,737

2,054

1,930

1,873

1,763

1,833

1,720

1,751

1,707

1,735

1,585

1,625

1,510

1,573

1,511

1,487

1,391

1,404

1,349

1,303

1,248

1,327

1,296

1,310

1,237

1,282

1,225

1,279

1,183

1,238

1,177

1,250

1,235

1,188

1,194

1,287

1,294

1,343

1,293

1,274

1,297

1,369

1,396

1,444

1,403

1,323

1,420

Operating expenses:
Selling, general and administrative expenses

978

1,092

1,012

968

869

953

870

886

860

885

800

815

794

832

772

779

716

776

729

700

668

752

741

743

666

724

658

661

631

639

589

648

659

620

629

642

596

684

634

634

628

648

665

671

651

610

655

Research and development expenses

300

308

306

280

280

288

289

275

261

264

254

244

235

256

232

222

210

243

221

220

192

208

212

206

191

217

217

223

204

238

220

213

215

231

229

223

212

224

230

232

253

257

258

263

257

252

253

Royalty expense

12

17

15

17

16

18

17

17

18

18

16

17

17

20

20

20

19

18

17

18

17

25

21

25

40

24

28

47

41

28

29

48

48

33

36

52

51

38

39

57

51

41

51

53

46

51

48

Loss on program termination

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

16

-

0

0

Amortization expense

201

200

178

161

160

163

148

147

141

141

139

142

143

138

136

135

136

135

131

116

113

111

109

109

109

105

101

101

103

100

99

99

97

96

97

96

132

132

129

124

128

131

126

126

128

131

135

Goodwill impairment charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

423

0

748

3,602

0

0

0

0

697

0

0

-31

1,848

-

-

-

-

-

-

Intangible asset impairment charges

198

1

0

37

67

0

0

34

1

1

3

0

0

-

7

-

-

-

10

9

-

18

12

110

55

0

0

53

0

-

13

129

-

-

9

12

-

0

5

0

60

-

-

10

-

155

0

Contingent consideration expense (benefit)

-108

-25

8

10

-28

-9

-13

-4

5

-2

-4

-24

-50

5

-13

33

4

37

40

19

27

37

-4

-96

-22

-14

23

18

-23

3

-20

1

10

-12

6

7

6

-

0

0

-

-

-

-

-

-

-

Purchased research and development

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17

-

-8

16

Acquisition-related milestone

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

250

-

-

-

-

-250

-

Restructuring charges (credits)

10

28

3

1

6

15

3

5

13

20

12

1

4

6

5

14

3

10

7

3

6

32

2

15

20

46

19

26

10

44

54

28

10

11

22

18

38

19

5

27

65

18

9

13

23

20

10

Litigation-related net charges (credits)

0

223

25

15

-148

85

18

0

0

89

-12

205

3

172

4

618

10

456

457

-1

193

637

139

267

-7

15

76

0

130

73

50

69

0

-

0

0

-

-

-

-

-

1,499

236

0

287

334

0

Gain on divestiture

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

12

-2

0

34

6

4

11

0

0

10

8

0

760

-

0

0

-

-

-

-

-

0

0

Operating expenses

1,591

1,844

1,547

1,489

1,222

1,512

1,333

1,359

1,300

1,416

1,208

1,400

1,146

1,433

1,163

1,821

1,098

1,631

1,648

1,084

1,224

1,820

1,232

1,379

1,040

1,155

1,122

1,059

1,513

1,121

1,771

4,837

1,039

1,017

1,020

1,050

972

995

1,042

1,043

2,783

2,600

1,345

1,169

1,392

1,295

1,117

Operating income (loss)

146

210

383

384

541

319

388

392

407

319

377

225

364

140

348

-334

293

-227

-299

219

24

-493

64

-69

197

127

103

220

-330

117

-594

-3,587

196

171

174

237

322

348

251

231

-1,486

-1,231

51

275

11

28

303

Other income (expense):
Interest expense

88

180

95

89

109

65

58

57

61

57

57

58

57

57

58

59

59

60

58

106

60

55

54

53

54

57

137

65

65

63

65

64

69

71

62

73

75

106

91

103

93

122

91

92

102

112

118

Other, net

-36

-36

-197

-150

25

41

126

12

-23

-35

-11

-76

-2

6

-33

-4

-6

-50

-10

-8

-15

-6

-7

18

3

-11

-6

-3

1

-3

-4

33

-4

0

-1

-6

26

-12

3

-9

4

6

-4

-3

-6

16

-85

Income (loss) before income taxes

22

-6

91

145

457

296

456

347

323

228

309

91

305

89

257

-397

228

-337

-367

105

-51

-554

3

-104

146

59

-40

152

-394

51

-663

-3,618

123

100

111

158

273

230

163

119

-1,575

-1,347

-44

180

-97

-68

100

Income tax expense (benefit)

12

-4,002

-35

-9

33

-90

24

-209

26

842

26

-55

15

-35

29

-190

26

-195

-169

3

-50

-255

-40

-108

13

-49

-35

22

-40

-10

1

-40

10

-7

-31

12

227

-6

-27

21

14

-271

50

22

-84

-6

2

Net income (loss)

11

3,996

126

154

424

386

432

555

298

-615

283

146

290

124

228

-207

202

-142

-198

102

-1

-299

43

4

133

108

-5

130

-354

61

-664

-3,578

113

107

142

146

46

236

190

98

-1,589

-1,076

-94

158

-13

-62

98

Net income (loss) per common share — basic

0.01

2.87

0.09

0.11

0.31

0.28

0.31

0.40

0.22

-0.45

0.21

0.11

0.21

0.09

0.17

-0.15

0.15

-0.11

-0.15

0.08

0.00

-0.22

0.03

0.00

0.10

0.07

0.00

0.10

-0.26

0.02

-0.48

-2.51

0.08

0.07

0.09

0.10

0.03

0.16

0.13

0.06

-1.05

-0.71

-0.06

0.10

-0.01

-0.04

0.07

Net income (loss) per common share — assuming dilution

0.01

2.83

0.09

0.11

0.30

0.27

0.31

0.40

0.21

-0.44

0.20

0.11

0.21

0.08

0.17

-0.15

0.15

-0.11

-0.15

0.08

0.00

-0.22

0.03

0.00

0.10

0.07

0.00

0.10

-0.26

0.02

-0.48

-2.51

0.08

0.07

0.09

0.10

0.03

0.17

0.12

0.06

-1.05

-0.71

-0.06

0.10

-0.01

-0.04

0.07

Pension termination charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

36

0

8

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-average shares outstanding
Basic

1,397

1,394

1,393

1,391

1,387

1,384

1,382

1,380

1,376

1,373

1,372

1,369

1,365

1,362

1,360

1,357

1,350

1,345

1,344

1,341

1,333

1,326

1,325

1,323

1,321

1,329

1,340

1,343

1,351

1,365

1,392

1,423

1,445

1,467

1,514

1,528

1,526

1,520

1,519

1,516

1,514

1,510

1,509

1,506

1,504

1,500

1,497

Assuming dilution

1,413

1,413

1,412

1,408

1,408

1,406

1,403

1,398

1,396

1,395

1,394

1,391

1,390

1,401

1,379

1,357

1,369

1,325

1,344

1,361

1,333

1,255

1,347

1,345

1,349

1,314

1,340

1,358

1,351

1,357

1,392

1,423

1,454

1,479

1,524

1,535

1,536

1,502

1,529

1,525

1,514

1,503

1,509

1,514

1,504

1,500

1,505